Home

Thursday, September 2, 2021

Bajaj Healthcare to start commercial production of Nimesulide API; stock gains

FDA Maharashtra (India), has granted permission to manufacture and sales the Nimesulide API in the domestic as well as in overseas market.

from India Infoline News Service https://ift.tt/3kIWmd6

No comments:

Post a Comment